Search Results
69 items found for " Devki D Sukhtankar"
Posts (34)
- 📰 GPCR Weekly News, July 31 to August 6, 2023
Devki D Sukhtankar and Pina M Cardarelli's research: Burixafor Hydrobromide (GPC-100) effects on hematopoietic
- Dopamine D 1 receptor-mediated β-arrestin signaling: Insight from pharmacology, biology, behavior...
August 2022 Dopamine D 1 receptor-mediated β-arrestin signaling: Insight from pharmacology, biology,
- Comparative study of neuropeptide signaling systems in Hemiptera
precursors and 48 putative neuropeptide G protein-coupled receptor (GPCR) genes were identified in D. research provides more knowledge on neuropeptide systems and sets the groundwork for the creation of novel D.
Other Pages (35)
- 23-01 Dr. GPCR Newsletter
Sakmar , Graeme Milligan , Sudarshan Rajagopal , Christel Menet , Laurent Sabbagh , Devki Suhktankar
- 22-12 Dr GPCR Newsletter
Sakmar , Graeme Milligan , Sudarshan Rajagopal , Christel Menet , Laurent Sabbagh , Devki Suhktankar Discovery of the thieno[2,3-d]pyrimidine-2,4-dione derivative 21a: A potent and orally bioavailable gonadotropin-releasing Multi-target Collaboration and License Agreement in Diabetes and Metabolic Diseases Sosei Heptares Enters R&D Treating Type 2 Diabetes and Obesity Special report 2022: Meet 20 women blazing trails in biopharma R&D
- LP2, a cyclic angiotensin-(1-7) analog extended with an N-terminal D-lysine, impairs growth of patient-derived xenografts of colorectal carcinoma in mice
GPCRs in Oncology and Immunology LP2, a cyclic angiotensin-(1-7) analog extended with an N-terminal D-lysine xenografts of colorectal carcinoma in mice Published date February 1, 2023 Abstract " LP2 is a 4, 7 D, L lanthionine-stabilized analog of angiotensin-(1-7), with an N-terminal D-lysine, resistant to breakdown